Clinical Report: Assessing Prognostic Factors in Oral Squamous Cell Carcinoma
Overview
This study validates the prognostic significance of tumor budding (TB) and tertiary lymphoid structures (TLS) in oral squamous cell carcinoma (OSCC). The combined TB/TLS index demonstrates superior prognostic ability compared to individual markers, leading to the development of a nomogram for predicting patient outcomes.
Background
Oral squamous cell carcinoma (OSCC) is a major subtype of head and neck malignancies, with significant global incidence and mortality rates. The current prognosis for OSCC patients remains suboptimal, necessitating improved prognostic tools. Understanding the roles of TB and TLS within the tumor microenvironment can enhance prognostic predictions and treatment strategies.
Data Highlights
{'format': 'Ensure the table is properly formatted and integrated into the report.'}
Key Findings
High-grade tumor budding (TB) is associated with poor survival outcomes in OSCC patients.
High-maturation tertiary lymphoid structures (TLS) correlate with improved survival rates.
The TB/TLS index provides better prognostic discrimination than either marker alone.
A nomogram incorporating the TB/TLS index shows reliable predictive performance.
External validation of the nomogram indicates moderate predictive capability despite cohort differences.
Clinical Implications
The integration of TB and TLS assessments can enhance prognostic accuracy for OSCC patients, guiding treatment decisions. Clinicians should consider the TB/TLS index when evaluating patient prognosis and tailoring therapeutic strategies.
Conclusion
This study underscores the importance of combining tumor budding and tertiary lymphoid structures in prognostic assessments for OSCC. The developed nomogram may serve as a valuable tool for predicting patient outcomes.